Kronos Worldwide, Inc. (KRO) Bundle
You're looking at Kronos Worldwide, Inc. (KRO) and asking the right question: why are major institutional players still holding or even adding shares when the stock's been hammered? Honestly, the headline numbers from the Q3 2025 earnings are tough to stomach, showing a net loss of $37.0 million, or $0.32 per share, a sharp reversal from the year prior. That kind of performance, driven by lower titanium dioxide selling prices, is why the stock price was sitting around $4.63 per share in early November 2025, down significantly from its 52-week high of nearly $13.00. But here's the defintely interesting part: the investor profile shows that institutions like Dimensional Fund Advisors Lp and Boston Partners are major owners, with the top institutional holders collectively owning over 22.9 million shares as of late Q3 2025. So, are these sophisticated investors simply trapped, or do they see a clear value opportunity in a cyclical bottom that the average retail investor is missing?
Who Invests in Kronos Worldwide, Inc. (KRO) and Why?
If you're looking at Kronos Worldwide, Inc. (KRO), the first thing you need to understand is that it's not a typical public company. The investor profile is dominated by a single, powerful insider, which dramatically shapes the stock's dynamics for everyone else. This high insider control means the available shares, or the public float, are very small, so price movements can be sharp.
The core of the ownership structure is clear: the company is overwhelmingly controlled by insiders, primarily Contran Corp., which holds a staggering 85.68% of the shares. This leaves a small slice for the rest of the market. The other key players are institutional investors, holding roughly 13.33% to 15.25% of the stock, with the remainder held by retail investors and other small entities. It's a tightly held stock, defintely.
The Institutional Heavyweights and Their Role
The institutional investors in Kronos Worldwide, Inc. aren't generally growth-focused hedge funds looking for a quick five-bagger. Instead, you see a mix of passive index funds and value-oriented asset managers. Firms like The Vanguard Group, Inc. and BlackRock, Inc. are major holders, but their positions-BlackRock, Inc. held about 1,625,462 shares as of mid-2025-are often driven by the stock's inclusion in broad market or small-cap value indices, not necessarily a deep conviction in the near-term TiO2 cycle. They are passive, long-term holders.
Here's a quick look at the top institutional types and their primary driver:
- Index Funds (Vanguard, BlackRock, Inc.): Mandated to hold KRO due to its inclusion in specific equity indices.
- Value Funds (Dimensional Fund Advisors LP, Boston Partners): Attracted by the stock's low valuation multiples during cyclical downturns.
- Hedge Funds (Renaissance Technologies LLC): Likely engaging in short-term, quantitative trading strategies due to the stock's low float and volatility.
Investment Motivations: Dividends and Cyclical Value
The primary attraction for non-insider investors boils down to two things: the dividend and the cyclical nature of the titanium dioxide (TiO2) market. Kronos Worldwide, Inc. is a major international producer of TiO2, a pigment used in everything from paint to plastics, making it highly sensitive to the global construction and manufacturing cycle.
For income-focused investors, the dividend is the main draw. As of November 2025, the company offers an annual dividend of $0.20 per share, translating to a yield in the range of 4.07% to 4.62%. This yield is notable, especially when compared to the broader market average. Value investors, on the other hand, are looking past the recent volatility.
Here's the quick math on the recent performance, which illustrates the cyclical risk:
| Metric (2025) | Q1 2025 | Q2 2025 |
|---|---|---|
| Net Income | $18.1 million (or $0.16/share) | Net Loss of $9.2 million (or $0.08/share) |
| Net Sales | $489.8 million | $494.4 million (slight decrease from Q2 2024) |
The jump from a strong Q1 profit to a Q2 loss, with first-half 2025 net income at only $8.9 million, shows the extreme sensitivity to production volumes and pricing. Value investors are buying when the stock is near its 52-week low of $4.10, betting on a rebound in the TiO2 cycle, which historically happens every few years.
The Core Investment Strategy: Buy-and-Wait
Given the high insider ownership, the most common strategy for the public float is a long-term holding approach, often characterized as Value Investing or a Dividend Income play. You're not buying Kronos Worldwide, Inc. for explosive, steady growth; you're buying it for the deep value when the TiO2 cycle is depressed or for the consistent dividend stream.
The presence of large, passive institutional investors means a significant portion of the float is sticky-they aren't selling unless the stock is removed from their benchmark index. This stability is critical for the dividend yield to remain attractive. The other side of the coin is the short-term traders, who jump in when the stock price is near its 52-week low of $4.10 (as of November 2025) and sell when it spikes, as it did toward its 52-week high of $11.97.
If you want to understand the foundational business that drives these cycles, you should review the company's background and operations: Kronos Worldwide, Inc. (KRO): History, Ownership, Mission, How It Works & Makes Money. The next step for you is to map the current TiO2 pricing trends against the company's cost structure. Finance: draft a sensitivity analysis on KRO's earnings per share (EPS) based on a 5% and 10% change in TiO2 selling prices by the end of the week.
Institutional Ownership and Major Shareholders of Kronos Worldwide, Inc. (KRO)
You want to know who is buying Kronos Worldwide, Inc. (KRO) and why, especially with the stock seeing volatility. The direct takeaway is that institutional investors, while holding a significant portion of the public float, are showing mixed sentiment in late 2025, largely reacting to the company's challenging financial performance in the titanium dioxide (TiO2) market.
As of the most recent filings, institutional investors-the mutual funds, pension funds, and investment banks-hold a total of approximately 22,950,947 shares of Kronos Worldwide, Inc.. This represents an institutional ownership of about 17.22% of the total shares outstanding, with the total value of these holdings sitting around $81 million as of November 2025. That's a concentrated group of buyers, so their moves matter.
Top Institutional Investors: Who's Buying KRO?
The largest institutional holders typically fall into two camps: passive index funds (like Vanguard and BlackRock, Inc.) and active quantitative or value-focused managers. For Kronos Worldwide, Inc., the top five institutional investors collectively hold a substantial position, signaling their long-term or quantitative belief in the company's value proposition, despite near-term headwinds.
Here's a quick look at the top institutional holders and their share counts based on Q3 2025 filings (as of September 30, 2025):
| Major Shareholder Name | Shares Held (as of 9/30/2025) |
|---|---|
| Dimensional Fund Advisors LP | 3,259,517 |
| Boston Partners | 2,948,114 |
| Vanguard Group Inc | 2,197,973 |
| BlackRock, Inc. | 1,625,462 |
| Renaissance Technologies LLC | 743,088 |
Dimensional Fund Advisors LP and Boston Partners, both known for their value and quantitative strategies, lead the pack. They are betting on a fundamental turnaround or a favorable valuation relative to the company's assets, which is the core of value investing.
Recent Shifts: Have Institutional Investors Increased or Decreased Their Stakes?
The recent sentiment has been mixed, which is a classic sign of a stock in transition. In the most recent reporting quarter (Q3 2025), Kronos Worldwide, Inc. saw a nearly equal split in activity: 63 institutional investors added shares to their portfolios, but 66 decreased their positions. This is not a strong conviction buy or sell signal from the market as a whole.
The key is to look at the size of the moves, not just the number of firms. For example, Boston Partners increased its stake by a notable 426,662 shares, representing a 16.921% jump in their holding. On the flip side, some investors exited entirely, like Luminus Management LLC, which removed 435,459 shares, a 100.0% reduction in their position during Q3 2025. When a fund completely sells out, it's defintely a strong vote of no confidence in the near-term outlook.
Here's the quick math on the largest passive holders: Vanguard Group Inc. and BlackRock, Inc. both slightly reduced their stakes by -3.743% and a negligible amount, respectively, as of September 30, 2025. They are generally passive, so minor shifts often reflect index rebalancing, but still, they weren't net buyers.
Impact of Institutional Investors on KRO's Strategy and Stock Price
These large investors play a crucial role, acting as both a floor and a ceiling for the stock price. When a company like Kronos Worldwide, Inc. reports a Q3 2025 net loss of $37.0 million and a 6% drop in net sales to $456.9 million, institutional selling pressure can drive the price down quickly. The stock price, which was around $11.67 a year ago, fell to about $4.63 per share by November 10, 2025, a clear reflection of the market's reaction to lower TiO2 prices and reduced demand.
The institutional presence also influences corporate strategy, especially for a company facing legislative and market challenges, as detailed in the Mission Statement, Vision, & Core Values of Kronos Worldwide, Inc. (KRO).
- Price Stability: Large, passive holders like Vanguard act as a stabilizing force, holding shares regardless of short-term news.
- Strategic Pressure: Active funds, such as those increasing their stake, buy because they anticipate a turnaround, often putting pressure on management to execute cost-cutting or operational improvements. Kronos Worldwide, Inc. is already implementing new cost reduction initiatives to improve its cost structure and operating cash flows.
- Liquidity: High institutional ownership can reduce the available public float, sometimes leading to sharper price movements when a major holder decides to sell a large block of shares.
The recent Q3 loss, partially due to a $19.3 million non-cash deferred tax expense from German tax legislation changes, is exactly the kind of one-time event that value investors will look past, while others focused on short-term earnings will sell. Your action here is to decide which camp you belong to: the short-term realist or the long-term value hunter.
Next Step: Finance: Analyze the Q3 2025 EBITDA of $0.6 million versus the prior year's $123.3 million to model the full-year 2026 cash flow projections by end of next week.
Key Investors and Their Impact on Kronos Worldwide, Inc. (KRO)
The investor profile for Kronos Worldwide, Inc. (KRO) is really a story of two groups: the long-term, controlling interest held by Contran Corp., and the large, but mostly passive, institutional funds. This dual structure means that while major fund managers track the stock, the ultimate strategic direction is largely set by the principal owner.
For you, this means understanding that KRO's stock movements are often less about activist pressure and more about the cyclical nature of the titanium dioxide (TiO2) market, plus any shifts in the controlling entity's strategy. It's a different kind of risk profile, honestly.
The Controlling Stake: Contran Corp.'s Dominance
The most important investor in Kronos Worldwide, Inc. isn't a BlackRock or a Vanguard; it's Contran Corp., which holds a substantial, controlling stake in the company. This relationship is foundational to KRO's governance and decision-making, which is crucial for any investor to grasp.
This level of ownership means that Contran Corp. has the power to elect the board of directors and approve major corporate actions, effectively setting the long-term strategy and capital allocation policy. You won't see a typical activist investor battle here, because the controlling party is already in charge. The influence is structural, not tactical.
- Influence is Structural: Contran Corp. controls the board and strategic direction.
- Less Activism: High insider ownership limits external activist campaigns.
- Capital Decisions: Major moves, like the recent note offering or dividend policy, are steered by this core group.
Institutional Giants and Their 2025 Positioning
Beyond the controlling interest, the rest of the float is held by the usual suspects-the major institutional asset managers. These are mostly passive index funds or quantitative strategies, buying KRO because it fits their mandates, not because they're planning a boardroom coup. They represent the passive money flow that influences stock liquidity and valuation multiples.
As of the September 30, 2025, 13F filings, the largest institutional holders collectively own millions of shares. Here's a quick look at the top four, showing their positions and recent movements, which tells you a lot about current sentiment:
| Notable Investor | Shares Held (as of Q3 2025) | Q3 2025 Change in Shares |
|---|---|---|
| Dimensional Fund Advisors LP | 3,259,517 | Down -2.131% |
| Boston Partners | 2,948,114 | Up 16.921% |
| Vanguard Group Inc. | 2,197,973 | Down -3.743% |
| BlackRock, Inc. | 1,625,462 | Down (small decrease) |
Here's the quick math: three of the four largest funds were net sellers, or slightly reduced their stake, in the most recent reported quarter. This suggests a cautious, if not slightly negative, sentiment among the largest passive and quantitative players, especially after the company reported a net loss of $37.0 million in the third quarter of 2025.
Recent Moves: A Mix of Caution and Opportunity
The recent investor activity shows a divergence. While the mega-funds like Vanguard Group Inc. and BlackRock, Inc. trimmed their positions, other active managers saw an opportunity. For instance, Boston Partners significantly increased its stake by over 16% in the Q3 2025 reporting period. This kind of move indicates a belief that the stock is either undervalued or that the TiO2 market cycle is nearing a trough and due for a rebound.
We also saw hedge funds making tactical trades. Luminus Management LLC, for example, added 260,300 shares in late 2024, and ExodusPoint Capital Management, LP added 121,747 shares in Q1 2025. These are the investors betting on a short-term inflection point, likely drawn by the company's Q1 2025 net income of $18.1 million, which had doubled year-over-year. But to be fair, the Q3 2025 net loss definitely dampened that optimism. If you want to dive deeper into the financial health driving these decisions, you can check out Breaking Down Kronos Worldwide, Inc. (KRO) Financial Health: Key Insights for Investors.
The clear action here is to watch for the next round of 13F filings to see if the net selling trend from the passive funds continues, or if the active buyers like Boston Partners are proven right by an improving market cycle.
Market Impact and Investor Sentiment
You're looking at Kronos Worldwide, Inc. (KRO) and seeing a disconnect: analysts are mostly bearish, but the stock has a history of high insider buying. The direct takeaway is that while Wall Street's consensus is a Strong Sell, the stock's fate is primarily tied to its majority owner and the titanium dioxide (TiO2) market's cyclical recovery, not the fluctuating sentiment of smaller institutional players.
The overall investor sentiment from the analyst community is defintely negative as of November 2025. Out of the analysts tracking the stock, the consensus is a 'Strong Sell,' with a target price averaging around $6.50 to $7.17. This bearish view stems from the company's recent financial performance. For the third quarter of 2025, Kronos Worldwide reported a net loss of $37.0 million, a sharp reversal from the net income of $71.8 million in the same quarter last year. That's a massive drop, so the analyst caution makes sense.
The institutional ownership picture is what really tells the story, though. Contran Corporation holds a dominant position, owning approximately 81.13% of the outstanding shares. This super-majority means the public float-the shares available for trading-is small, which can lead to higher volatility. The key institutional investors, including The Vanguard Group, Inc. and BlackRock, Inc., are significant, but their combined holdings are dwarfed by Contran's stake. For instance, BlackRock, Inc. holds about 1.42% of the shares, or 1,631,240 shares, as of June 2025. When the majority owner is this large, their long-term strategy is the primary driver, overshadowing short-term institutional trading activity.
- Contran Corp. controls 81.13% of Kronos Worldwide's stock.
- BlackRock, Inc. holds 1.42% of the company's shares.
- Insider sentiment is 'Positive' due to open-market purchases.
Recent Market Reactions and Ownership Moves
The stock market's reaction to recent news has been mixed, reflecting the underlying tension between poor fundamentals and positive insider action. In the last three years, the share price has fallen by about 35%, lagging the broader market. Still, in the days leading up to November 21, 2025, the stock price gained 4.85% on the last trading day, a small technical positive sign. This recent uptick was supported by an increase in trading volume and a 'Positive' insider sentiment, with insiders collectively purchasing $718.5K worth of shares in high-impact open-market transactions over the last year.
What this estimate hides is the mixed institutional trading. In the most recent quarter reported, 87 institutional investors decreased their positions, while 56 added shares. This churn shows smaller institutions are actively debating the stock's future. For a deeper dive into the company's strategic direction, you should review the Mission Statement, Vision, & Core Values of Kronos Worldwide, Inc. (KRO).
Analyst Perspectives on Key Investor Impact
Analysts are focused on the core business, which has struggled in 2025. The full-year 2025 revenue is forecasted at $1.88 billion, a slight dip from the previous year's $1.89 billion. More critically, the full-year Earnings Per Share (EPS) is forecasted to be a loss of $-0.03. Here's the quick math: with a net loss of $37.0 million in Q3 2025 alone, the path back to profitability is steep, driven by lower average selling prices for titanium dioxide and legislative changes in Germany.
The impact of the majority shareholder, Contran Corp., is viewed as a stability factor, but also a limit on potential activist pressure. Since the float is so small, institutional investors like Dimensional Fund Advisors LP and Boston Partners Global Investors, Inc. are essentially passive holders, not change agents. Their buying or selling is less about forcing a strategic shift and more about portfolio rebalancing against the backdrop of the company's Q3 2025 net sales decrease of 6%.
To be fair, the analyst price targets, while based on a 'Strong Sell' rating, still imply a significant upside from the current stock price, suggesting that a successful turnaround in the TiO2 market could quickly re-rate the stock. The low price target set by Goldman Sachs in October 2025 was $6.00, which is still well above the recent trading price of around $4.54.
| 2025 Financial Metric (YTD/Forecast) | Amount/Value | Context |
|---|---|---|
| Q3 2025 Net Loss | $37.0 million | Significant decline from Q3 2024 net income. |
| Q3 2025 Net Sales Change | Decreased by 6% | Due to reduced sales volumes in European and export markets. |
| First Six Months 2025 Net Income | $8.9 million | Down from $27.6 million in the first six months of 2024. |
| Full Year 2025 Revenue Forecast | $1.88 billion | Slightly below 2024 revenue of $1.89 billion. |
| Consensus Price Target | $6.50 - $7.17 | Implies a potential upside despite the Strong Sell rating. |
Next step: Finance should model a scenario where the TiO2 market recovers and the average selling price increases by 5% in Q4 2025 to gauge the impact on the full-year EPS forecast.

Kronos Worldwide, Inc. (KRO) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.